Source: New Zealand Ministry of Health
The Ministry of Health has today announced the new Executive Steering Group membership which will support the new Dunedin Hospital project through the next stages.
The new Executive Steering Group includes:
- Evan Davies – current chair of the Capital Investment Committee and a member of the Christchurch Hospital Redevelopment Partnership Group. Mr Davies will chair the Executive Steering Group.
- Dr Margaret Wilsher – former Southern Partnership Group member and current Chief Medical Officer at Auckland DHB.
- Dr Nick Baker – current Chief Medical Officer at Nelson Marlborough DHB.
- Dr Tony Lanigan – professional civil engineer and a member of the Christchurch Hospital Redevelopment Partnership Group.
- A local iwi representative will be nominated, working with local groups Te Rûnanga o Ôtâkou and Kâti Huirapa ki Puketeraki, in consultation with Ngâi Tahu leadership.
- The Southern DHB Chair is also a member of the Group, and an international expert will also be appointed with experience from an overseas health infrastructure body such as Health Infrastructure New South Wales.
“The Executive Steering Group members provide a mix of strong clinical and industry expertise with a depth of experience and capability on health infrastructure project governance and delivery, risk management and clinical design,” Director-General of Health, Dr Ashley Bloomfield says.
“Local input to the project will continue to be important. In addition to a local iwi representative on the Executive Steering Group, the Local Advisory Group in Dunedin will continue to provide local advice and insights”.
“These new governance arrangements for the new Dunedin Hospital project will ensure the progress made to date continues as we head into the next stages of this complex project, which will be the largest ever hospital build in New Zealand”
“The new Dunedin Hospital will showcase world class infrastructure, make more use of digital technology and support new models of care. It will bring economic benefits to the region and most importantly, deliver improved equitable health outcomes for New Zealanders,” Dr Bloomfield said.
Notes to editors
The Executive Steering Group is expected to hold its first meeting in Dunedin in late January 2021. The draft terms of reference will be refined by the Group.
The Southern Partnership Group, which will be disestablished on 31 December 2020, will assist the new Group to ensure a smooth transition.
Representatives from Treasury, Infrastructure Commission, Capital Investment Committee and Local Advisory Group will also attend the meetings.
The appointments were approved by the Director-General of Health and have been endorsed by Cabinet.
Mr Davies is the current Chair of the Capital Investment Committee and Director of Todd Property Group Ltd. He is also a member of the Canterbury Hospital Redevelopment Partnership Group.
He is a trustee of several substantial charitable organisations and a director of several public sector enterprises.
Dr Margaret Wilsher
Dr Wilsher is a practising respiratory physician, clinical teacher and researcher, and current Chief Medical Officer at Auckland DHB.
She has extensive experience in health sector governance as a prior member of the New Dunedin Hospital Southern Partnership Group, Christchurch Hospital Redevelopment Partnership Group and the Capital Investment Committee.
Dr Nick Baker
Dr Baker is the Chief Medical Officer at Nelson Marlborough DHB and a member of Paediatric Society of New Zealand.
He is also a senior clinical lecturer of community child health for the University of Otago, Wellington School of Medicine, and Deputy Chair of the National CMO Group.
Dr Tony Lanigan
Dr Lanigan, a professional civil engineer, was Chancellor of Auckland University of Technology in 2000-2001, a founding director in New Zealand of the international charity, Habitat for Humanity, and a former General Manager of Fletcher Construction.
Dr Lanigan is also a member of the Canterbury Hospital Redevelopment Partnership Group, and previously served on the Southern Partnership Group until 2018.
021 576 283